Cumberland Pharmaceuticals (CPIX) Gains from Sales and Divestitures (2014 - 2015)
Cumberland Pharmaceuticals' (CPIX) quarterly Gains from Sales and Divestitures came in at $81270.0 in Q4 2015, up 619.2% year-on-year from $11300.0 in Q4 2014, and up 619.2% quarter-over-quarter from $11300.0 in Q4 2014.
Cumberland Pharmaceuticals (CPIX) Gains from Sales and Divestitures (2014 - 2015) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $81270.0 for Q4 2015.
- Gains from Sales and Divestitures for Q4 2015 came in at $81270.0, up 619.2% year-over-year; the trailing twelve-month figure through Dec 2015 was $81270.0 (up 619.2% YoY), and the FY2015 annual result was $81270.0, up 619.2% from the prior year.
- Gains from Sales and Divestitures came in at $81270.0 for Q4 2015 at Cumberland Pharmaceuticals, up from $11300.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $81270.0 in Q4 2015 to a low of $11300.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 81,270.00 |
| Dec 31, 2015 | 81,270.00 |
| Dec 31, 2014 | 11,300.00 |
| Dec 31, 2014 | 11,300.00 |